ZA200804734B - Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms - Google Patents

Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms

Info

Publication number
ZA200804734B
ZA200804734B ZA200804734A ZA200804734A ZA200804734B ZA 200804734 B ZA200804734 B ZA 200804734B ZA 200804734 A ZA200804734 A ZA 200804734A ZA 200804734 A ZA200804734 A ZA 200804734A ZA 200804734 B ZA200804734 B ZA 200804734B
Authority
ZA
South Africa
Prior art keywords
methods
dosage forms
sustained release
oral dosage
release oral
Prior art date
Application number
ZA200804734A
Inventor
Sathyan Gaytri
Davar Nipun
Hastedt Jayne
Pors Linda
Casadevall Gemma
Cruz Evangeline
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA200804734B publication Critical patent/ZA200804734B/en

Links

ZA200804734A 2005-10-31 2008-05-30 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms ZA200804734B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73199505P 2005-10-31 2005-10-31

Publications (1)

Publication Number Publication Date
ZA200804734B true ZA200804734B (en) 2009-11-25

Family

ID=38069863

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804734A ZA200804734B (en) 2005-10-31 2008-05-30 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms

Country Status (2)

Country Link
CN (2) CN1957909B (en)
ZA (1) ZA200804734B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105287434A (en) * 2009-03-18 2016-02-03 赢创罗姆有限公司 Ethanol influence-resistant controlled-release medicine composition adopting coating containing neutral vinyl polymers and excipients
CA2788659C (en) * 2010-02-24 2015-05-05 Pfizer Inc. Veterinary compositions
CN108309949B (en) * 2018-03-15 2020-04-07 西南药业股份有限公司 Preparation method of morphine osmotic pump tablet and product thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
ATE322892T1 (en) * 1997-07-02 2006-04-15 Euro Celtique Sa STABILIZED SUSTAINED-RELEASE TRAMADOL FORMULATIONS
PL341309A1 (en) * 1997-12-22 2001-04-09 Euro Celtique Method of preventing overdosage of opioidic preparations

Also Published As

Publication number Publication date
CN1957909B (en) 2013-09-11
CN1957909A (en) 2007-05-09
CN101351202A (en) 2009-01-21

Similar Documents

Publication Publication Date Title
HK1106451A1 (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
IL268462A (en) Dosage forms of risedronate
IL182964A0 (en) Gabapentin prodrug sustained release oral dosage forms
LT2046298T (en) Pharmaceutical dosage form containing pharmaceutically acceptable solubilizing composition
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
IL194277A0 (en) Solid oral dosage form containing an enhancer
EP2040731A4 (en) Solid oral dosage form containing an enhancer
PL2077729T3 (en) Probiotic oral dosage forms
IL193727A0 (en) Dosage forms for administering combinations of drugs
EP1750674A4 (en) Microparticles for oral delivery
PL2457563T3 (en) Zero-order modified release solid dosage forms
IL188313A0 (en) Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate
PL1906961T3 (en) Solid dosage formulations of fentanyl having improved buccal adsorption
ZA200706731B (en) Dosage form and method for sustained release of a substituted pyrazine compound
IL177402A0 (en) Composition for oral administration of tamsulosin hydrochloride
ZA200610770B (en) Dosage form for delivery of multiple drug forms
IL179992A0 (en) Immediate release formulations of memantine oral dosage forms
GB0616703D0 (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
GB0612326D0 (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
EP1765340A4 (en) Sustained release composition for oral administration of niacin
ZA200804734B (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
GB0403808D0 (en) Films for use as dosage forms
EP1932923A4 (en) Method for determination of effective dose of methotrexate
SE0602280L (en) Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms
IL202272A0 (en) Process for forming solid oral dosage forms of angiotensin ii receptor antagonists